Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL

Journal of Immunology

Volumn 183, Issue 4, 2009, Pages 2286-2293

  Pilz, Andreas ^a   Kratky, Wolfgang ^a   Stockinger, Silvia ^a   Simma, Olivia ^a,c   Kalinke, Ulrich ^d,e   Lingnau, Karen ^b   Von Gabain, Alexander ^b   Stoiber, Dagmar ^c   Sexl, Veronika ^c   Kolbe, Thomas ^b   Rülicke, Thomas ^b   Müller, Mathias ^b   Decker, Thomas ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d PAUL EHRLICH INSTITUT   (Germany)

^e INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; STAT1 PROTEIN; TOLL LIKE RECEPTOR 9; EPITOPE; PEPTIDE FRAGMENT; SERINE; STAT1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CONTROL GROUP; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; CYTOTOXICITY TEST; GENETICS; HOMEOSTASIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; SERINE; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, CYTOTOXIC; TRANS-ACTIVATORS;

EID: 70149123505     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901383     Document Type: Article

References (56)

1. Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651-662.
2. O'Shea, J. J., and P. J. Murray. 2008. Cytokine signaling modules in inflammatory responses. Immunity 28: 477-487.
3. Stockinger, S., and T. Decker. Stats and infection. In Jak-Stat Pathway in Disease. A. Stephanou, ed. Austin, TX: Landes Bioscience; 2008: 1-15.
4. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450. (Pubitemid 26058569)
5. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442.
6. Zhang, S. Y., S. Boisson-Dupuis, A. Chapgier, K. Yang, J. Bustamante, A. Puel, C. Picard, L. Abel, E. Jouanguy, and J. L. Casanova. 2008. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-λ in host defense. Immunol. Rev. 226: 29-40.
7. Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282: 20059-20063.
8. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.
9. Kovarik, P., M. Mangold, K. Ramsauer, H. Heidari, R. Steinborn, A. Zotter, D. E. Levy, M. Muller, and T. Decker. 2001. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20: 91-100.
10. Sadzak, I., M. Schiff, I. Gattermeier, R. Glinitzer, I. Sauer, A. Saalmuller, E. Yang, B. Schaljo, and P. Kovarik. 2008. Recruitment of STAT-1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain. Proc. Natl. Acad. Sci. USA 105: 8944-8949.
11. Kovarik, P., D. Stoiber, P. A. Eyers, R. Menghini, A. Neininger, M. Gaestel, P. Cohen, and T. Decker. 1999. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway. Proc. Natl. Acad. Sci. USA 96: 13956-13961.
12. Ramsauer, K., M. Farlik, G. Zupkovitz, C. Seiser, A. Kroger, H. Hauser, and T. Decker. 2007. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible gbp2 gene. Proc. Natl. Acad. Sci. USA 104: 2849-2854.
13. Varinou, L., K. Ramsauer, M. Karaghiosoff, T. Kolbe, K. Pfeffer, M. Muller, and T. Decker. 2003. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-γ-dependent innate immunity. Immunity 19: 793-802.
14. Decker, T., S. Stockinger, M. Karaghiosoff, M. Muller, and P. Kovarik. 2002. IFNs and STATs in innate immunity to microorganisms. J. Clin. Invest. 109: 1271-1277.
15. Lee, C. K., E. Smith, R. Gimeno, R. Gertner, and D. E. Levy. 2000. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J. Immunol. 164: 1286-1292.
16. Tanabe, Y., T. Nishibori, L. Su, R. M. Arduini, D. P. Baker, and M. David. 2005. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-αβ responses in T lymphocytes. J. Immunol. 174: 609-613. (Pubitemid 40094251)
17. Gil, M. P., R. Salomon, J. Louten, and C. A. Biron. 2006. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 107: 987-993.
18. Miyagi, T., M. P. Gil, X. Wang, J. Louten, W. M. Chu, and C. A. Biron. 2007. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J. Exp. Med. 204: 2383-2396.
19. Nguyen, K. B., W. T. Watford, R. Salomon, S. R. Hofmann, G. C. Pien, A. Morinobu, M. Gadina, J. J. O'Shea, and C. A. Biron. 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection. Science 297: 2063-2066.
20. Dondi, E., L. Rogge, G. Lutfalla, G. Uze, and S. Pellegrini. 2003. Down-modulation of responses to type I IFN upon T cell activation. J. Immunol. 170: 749-756. (Pubitemid 36070525)
21. Durbin, J. E., A. Fernandez-Sesma, C. K. Lee, T. D. Rao, A. B. Frey, T. M. Moran, S. Vukmanovic, A. Garcia-Sastre, and D. E. Levy. 2000. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164: 4220-4228.
22. Fallarino, F., and T. F. Gajewski. 1999. Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1. J. Immunol. 163: 4109-4113. (Pubitemid 29474472)
23. + T lymphocytes during primary response. J. Immunol. 173: 3740-3747.
24. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469. (Pubitemid 40504523)
25. Havenar-Daughton, C., G. A. Kolumam, and K. Murali-Krishna. 2006. Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176: 3315-3319. (Pubitemid 43363977)
26. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
27. Thompson, L. J., G. A. Kolumam, S. Thomas, and K. Murali-Krishna. 2006. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 177: 1746-1754.
28. Aichele, P., H. Unsoeld, M. Koschella, O. Schweier, U. Kalinke, and S. Vucikuja. 2006. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 176: 4525-4529.
29. Nagarajan, U. M., D. Prantner, J. D. Sikes, C. W. Andrews, Jr., A. M. Goodwin, S. Nagarajan, and T. Darville. 2008. Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect. Immun. 76: 4642-4648.
30. + T-cell memory. Nat. Rev. Immunol. 8: 107-119.
31. Rengarajan, J., S. J. Szabo, and L. H. Glimcher. 2000. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today 21: 479-483.
32. + T cells to increase their abundance during virus infection. J. Exp. Med. 201: 1053-1059.
33. + T cell homeostasis by perforin and interferon-γ. Science 290: 1354-1358.
34. Refaeli, Y., L. Van Parijs, S. I. Alexander, and A. K. Abbas. 2002. Interferon γ is required for activation-induced death of T lymphocytes. J. Exp. Med. 196: 999-1005.
35. Dalod, M., T. Hamilton, R. Salomon, T. P. Salazar-Mather, S. C. Henry, J. D. Hamilton, and C. A. Biron. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J. Exp. Med. 197: 885-898.
36. Le Bon, A., G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardelli, and D. F. Tough. 2001. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14: 461-470.
37. + T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4: 1009-1015.
38. Jackson, S. H., C. R. Yu, R. M. Mahdi, S. Ebong, and C. E. Egwuagu. 2004. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J. Immunol. 172: 2307-2315.
39. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
40. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742.
41. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
42. DJ rearrangement. Cell 68: 855-867.
43. Scheicher, C., M. Mehlig, R. Zecher, and K. Reske. 1992. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 154: 253-264.
44. Lu, L., M. Hsieh, T. B. Oriss, P. A. Morel, T. E. Starzl, A. S. Rao, and A. W. Thomson. 1995. Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunology 84: 127-134.
45. Reutterer, B., S. Stockinger, A. Pilz, D. Soulat, R. Kastner, S. Westermayer, T. Rulicke, M. Muller, and T. Decker. 2008. Type I IFN are host modulators of strain-specific Listeria monocytogenes virulence. Cell. Microbiol. 10: 1116-1129.
46. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
47. Schellack, C., K. Prinz, A. Egyed, J. H. Fritz, B. Wittmann, M. Ginzler, G. Swatosch, W. Zauner, C. Kast, S. Akira, A. von Gabain, M. Buschle, and K. Lingnau. 2006. IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses. Vaccine 24: 5461-5472.
48. Das, G., S. Sheridan, and C. A. Janeway, Jr. 2001. The source of early IFN-γ that plays a role in Th1 priming. J. Immunol. 167: 2004-2010. (Pubitemid 32747507)
49. + T cells in protective immunity to Listeria monocytogenes. J. Immunol. 179: 2457-2466.
50. Bach, P., E. Kamphuis, B. Odermatt, G. Sutter, C. J. Buchholz, and U. Kalinke. 2007. Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies. J. Immunol. 178: 5839-5847. (Pubitemid 46674381)
51. Lee, C. K., R. Gimeno, and D. E. Levy. 1999. Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes. J. Exp. Med. 190: 1451-1464.
52. Kovacic, B., D. Stoiber, R. Moriggl, E. Weisz, R. G. Ott, R. Kreibich, D. E. Levy, H. Beug, M. Freissmuth, and V. Sexl. 2006. STAT1 acts as a tumor promoter for leukemia development. Cancer Cell 10: 77-87.
53. Gamero, A. M., and A. C. Larner. 2000. Signaling via the T cell antigen receptor induces phosphorylation of STAT-1 on serine 727. J. Biol. Chem. 275: 16574-16578.
54. Maldonado, R. A., M. A. Soriano, L. C. Perdomo, K. Sigrist, D. J. Irvine, T. Decker, and L. H. Glimcher. 2009. Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse. J. Exp. Med. 206: 877-892.
55. Surh, C. D., and J. Sprent. 2008. Homeostasis of naive and memory T cells. Immunity 29: 848-862.
56. + regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199: 25-34.